The soluble form of RAGE as a prognostic marker in melanoma

被引：0
|
作者：
Wagner, N. B. [1 ,2 ]
Petzinger, D. [1 ,2 ]
Lichtenberger, R. [1 ,2 ]
Holland-Letz, T. [3 ]
Findeisen, P. [4 ]
Umansky, V [1 ,2 ]
Utikal, J. [1 ,2 ]
Enk, A. H. [5 ]
Gebhardt, C. [1 ,2 ]
机构：
[1] German Canc Res Ctr, Skin Canc Unit, Heidelberg, Germany
[2] Univ Med Ctr Mannheim, Dept Dermatol, Mannheim, Germany
[3] German Canc Res Ctr, Dept Biostat, Heidelberg, Germany
[4] Univ Med Ctr Mannheim, Inst Clin Chem, Mannheim, Germany
[5] Univ Heidelberg Hosp, Dept Dermatol, Heidelberg, Germany
来源：
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2013年 / 11卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：904 / 905
页数：2
相关论文
共 50 条
  • [31] Soluble receptor for advanced glycation end products (RAGE) is a prognostic factor for heart failure
    Koyama, Yo
    Takeishi, Yasuchika
    Niizeki, Takeshi
    Suzuki, Satoshi
    Kitahara, Tatsuro
    Sasaki, Toshiki
    Kubota, Isao
    JOURNAL OF CARDIAC FAILURE, 2008, 14 (02) : 133 - 139
  • [32] A quantitative measurement of cells in melanoma tissue as a novel prognostic marker
    Gurr, C. L.
    Saldanha, G.
    Bamford, M.
    JOURNAL OF PATHOLOGY, 2024, 264 : S16 - S17
  • [33] Lecithin retinol acyltransferase as a potential prognostic marker for malignant melanoma
    Hassel, Jessica C.
    Amann, Philipp M.
    Schadendorf, Dirk
    Eichmueller, Stefan B.
    Nagler, Markus
    Bazhin, Alexandr V.
    EXPERIMENTAL DERMATOLOGY, 2013, 22 (11) : 757 - 759
  • [34] Use of oncogene expression as an independent prognostic marker for primary melanoma
    Grover, R
    Pacifico, MD
    Wilson, GD
    Sanders, R
    ANNALS OF PLASTIC SURGERY, 2003, 50 (02) : 183 - 187
  • [35] NBS1 expression as a prognostic marker in uveal melanoma
    Ehlers, JP
    Harbour, JW
    CLINICAL CANCER RESEARCH, 2005, 11 (05) : 1849 - 1853
  • [36] NM-23 EXPRESSION AS A PROGNOSTIC MARKER IN METASTATIC MELANOMA
    XERRI, L
    BATTYANI, Z
    BONERANDI, JJ
    HASSOUN, J
    GROB, JJ
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1995, 104 (01) : 159 - 159
  • [37] 2-Methoxyestradiol - A novel prognostic marker in malignant melanoma?
    Hrgovic, I.
    Kleemann, J.
    Doll, M.
    Loquai, C.
    Kaufmann, R.
    Meissner, M.
    EXPERIMENTAL DERMATOLOGY, 2018, 27 (03) : E24 - E24
  • [38] Expression of the SST receptor 2 in uveal melanoma is not a prognostic marker
    Mariam Kouch-el Filali
    Emine Kilic
    Marleen Melis
    Annelies de Klein
    Marion de Jong
    Gregorius P. M. Luyten
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2008, 246
  • [39] Serum Amyloid A As a Prognostic Marker in Melanoma Identified by Proteomic Profiling
    Findeisen, Peter
    Zapatka, Marc
    Peccerella, Teresa
    Matzk, Heike
    Neumaier, Michael
    Schadendorf, Dirk
    Ugurel, Selma
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (13) : 2199 - 2208
  • [40] S 100 B: a prognostic marker in malignant melanoma.
    Hansson, LO
    Djuren, E
    Dijlai-Merzog, R
    Nilsson, B
    Hansson, J
    CLINICAL CHEMISTRY, 1998, 44 : A46 - A47
12345